UBS Group AG - CIPHER PHARMACEUTICALS INC ownership

CIPHER PHARMACEUTICALS INC's ticker is CPHRF and the CUSIP is 17253X105. A total of 18 filers reported holding CIPHER PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CIPHER PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$1,000
-85.7%
149
-89.7%
0.00%
Q1 2016$7,000
+250.0%
1,444
+242.2%
0.00%
Q3 2015$2,000
-84.6%
422
-71.4%
0.00%
Q2 2015$13,000
+116.7%
1,474
+107.3%
0.00%
Q1 2015$6,0007110.00%
Other shareholders
CIPHER PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Raffles Associates 447,800$1,659,0001.74%
Grandeur Peak Global Advisors, LLC 1,506,600$5,566,0001.24%
MONTRUSCO BOLTON INVESTMENTS INC. 1,920,607$7,091,0000.61%
TAYLOR ASSET MANAGEMENT INC 526,900$1,954,0000.41%
ARMISTICE CAPITAL, LLC 300,000$1,115,0000.38%
INTACT INVESTMENT MANAGEMENT INC. 734,900$3,601,0000.16%
AWM Investment Company, Inc. 220,000$816,0000.16%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 638,000$2,356,0000.05%
ACADIAN ASSET MANAGEMENT LLC 739,684$2,729,0000.02%
EverPoint Asset Management, LLC 150,000$556,0000.01%
View complete list of CIPHER PHARMACEUTICALS INC shareholders